Inventor

Ask Puschl

Inventor
Frederiksberg, DK

Overview

27→
Patents
2006–2020
Patent span
Human necessities
Primary field (CPC A)

Patents· 27 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds38%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations36%
A61KPreparations for medical, dental or toiletry purposes24%
A61FFilters implantable into blood vessels1%
C07CAcyclic or carbocyclic compounds1%
PatentTitleYear
10,844,029Phenyl-piperazine derivatives as serotonin reuptake inhibitors20209,889,122'Positive allosteric modulators of nicotinic acetylcholine receptor'20189,801,878'Quinoline derivatives as PDE10A enzyme inhibitors'20179,708,280'Phenyl-piperazine derivatives as serotonin reuptake inhibitors'20179,669,029'Heteroaromatic phenylimidazole derivatives as PDE10A enzyme inhibitors'20179,549,919'Positive allosteric modulators of nicotinic acetylcholine receptor'20179,216,986'Quinoline derivatives as PDE10A enzyme inhibitors'20159,096,589'Heteroaromatic phenylimidazole derivatives as PDE10A enzyme inhibitors'20159,090,575'Phenyl-piperazine derivatives as serotonin reuptake inhibitors'20159,050,327'Positive allosteric modulators of nicotinic acetylcholine receptor'20159,023,870'Positive allosteric modulators of nicotinic acetylcholine receptor'20158,927,738'2-arylimidazole derivatives as PDE10A enzyme inhibitors'20158,815,914'Positive allosteric modulators of nicotinic acetylcholine receptor'20148,785,653'(3-aryl-1H-1,2,4-triazol-5-yl)-linked heterocycle derivatives'20148,765,790'Positive allosteric modulators of nicotinic acetylcholine receptor'20148,598,213'Positive allosteric modulators of nicotinic acetylcholine receptor'20138,501,797'(2-aryl-1H-imidazol-4-yl)-linked heterocycle derivatives'20138,501,795'(3-aryl-1H-1,2,4-triazol-5-yl)-linked heterocycle derivatives'20138,129,530'Catecholamine derivatives and prodrugs thereof'20128,110,567'Phenyl-piperazine derivatives as serotonin reuptake inhibitors'20128,067,410'Phenolic and catecholic amines and prodrugs thereof'20117,732,463'4-(2-phenylsulfanyl-phenyl)-piperidine derivatives as serotonin reuptake inhibitors'20107,618,967'Indane compounds'20097,351,734'Aminoindane derivatives as serotonin and norepinephrine uptake inhibitors'20087,148,238'Phenyl-piperazine derivatives as serotonin reuptake inhibitors'20067,144,884'Phenyl-piperazine derivatives as serotonin reuptake inhibitors'20067,138,407'Phenyl-piperazine derivatives as serotonin reuptake inhibitors'2006

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2006–2015Patents assigned to LUNDBECK & CO AS H (21)· patent assignee history
2006–2020Based in Frederiksberg, DK· patent location history
2011–2012Patents assigned to BANG-ANDERSEN BENNY (3)· patent assignee history
2013–2015Patents assigned to KEHLER JAN (3)· patent assignee history
2013–2015Patents assigned to KILBURN JOHN PAUL (3)· patent assignee history
2017–2020Patents assigned to H LUNDBECK AS (6)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
LUNDBECK & CO AS H212006–2015
H LUNDBECK AS62017–2020
BANG-ANDERSEN BENNY32011–2012
KEHLER JAN32013–2015
KILBURN JOHN PAUL32013–2015
Locations
LocationPatentsSpan
Frederiksberg, DK272006–2020